Understanding Immuno-oncology Trials

Understanding Immuno-oncology Trials
Publish Date:
October 13, 2014
Sharon Moore, MD

The immune system is a very finely tuned system and is designed to protect the body against attack from pathogens, including viruses, bacteria and parasites, by targeting and destroying them. Studies of immunotherapeutics in development for the treatment of cancer can be longer and more complex than small molecule chemotherapeutics, creating treatments that are likely to be more expensive when they reach the market.

This paper discusses how the immunotherapeutic approach created products that have potential to be safer and more effective, improving patients’ outcomes and quality of life, and reducing the impact and sequelae of the adverse drug events associated with traditional chemotherapeutic approaches.